Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00899210
What this trial is testing

Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University Hospital, Grenoble 75
Testing effectiveness (Phase 2)Study completedNCT00191984
What this trial is testing

The Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Eli Lilly and Company 46
Post-approval studies (Phase 4)Study completedNCT03564938
What this trial is testing

Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

Who this might be right for
Metastatic Colorectal Cancer
Bayer 100
Testing effectiveness (Phase 2)Ended earlyNCT00019747
What this trial is testing

Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Institutes of Health Clinical Center (CC) 39
Testing effectiveness (Phase 2)Looking for participantsNCT04689347
What this trial is testing

5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 27
Testing effectiveness (Phase 2)UnknownNCT03271255
What this trial is testing

Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)

Who this might be right for
Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal Neoplasms+1 more
Shenzhen People's Hospital 80
Testing effectiveness (Phase 2)UnknownNCT01110785
What this trial is testing

Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Leiden University Medical Center 46
Large-scale testing (Phase 3)Looking for participantsNCT04861558
What this trial is testing

Efficacy of Hyperthermic Intraperitoneal Chemotherapy

Who this might be right for
Colorectal CancerPeritoneal Metastases
Uppsala University 213
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableLooking for participantsNCT01479608
What this trial is testing

Liver Transplantation and Colorectal Cancer

Who this might be right for
Colorectal CancerLiver Metastasis
Oslo University Hospital 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06999252
What this trial is testing

Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients

Who this might be right for
Colon Cancer
Fudan University 20
Testing effectiveness (Phase 2)Ended earlyNCT02204332
What this trial is testing

Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment

Who this might be right for
Colorectal Cancer
Hospital Clinico Universitario de Santiago 38
Early research (Phase 1)Study completedNCT00379132
What this trial is testing

131-I-TM-601 Study in Adults With Solid Tumors

Who this might be right for
Breast CancerNon-Small Cell Lung CancerMelanoma+5 more
TransMolecular 60
Not applicableStudy completedNCT01039506
What this trial is testing

An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Daiichi Sankyo Co., Ltd. 1,376
Not applicableStudy completedNCT02827565
What this trial is testing

Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Institut de Cancérologie de Lorraine 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04245865
What this trial is testing

Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Vejle Hospital 83
Large-scale testing (Phase 3)Looking for participantsNCT06750094
What this trial is testing

Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Who this might be right for
Colorectal Neoplasms
Janssen Research & Development, LLC 700
Testing effectiveness (Phase 2)Study completedNCT01763307
What this trial is testing

Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI

Who this might be right for
Rash Due to Epidermal Growth Factor Receptor Inhibitors
Hadassah Medical Organization 18
Testing effectiveness (Phase 2)Study completedNCT01047475
What this trial is testing

A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675)

Who this might be right for
Colorectal Cancer
Microbio Co Ltd 72
Early research (Phase 1)Study completedNCT03095781
What this trial is testing

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Colorectal Carcinoma+12 more
Emory University 47
Next Page